AI assistant
MACROGENICS INC — Director's Dealing 2020
Sep 21, 2020
34129_dirs_2020-09-21_90c927ad-861a-443a-9b1a-d939b61dba91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-09-17
Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-17 | Common Stock | S | 44512 | $29.88 | Disposed | 102146 | Direct |
| 2020-09-18 | Common Stock | S | 18339 | $32 | Disposed | 83807 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $28.59 to $31.35. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.01. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.